1 - 25 of 26 results for author:"Nadler L.M." in Literature citations
Results Customize
› Repeat search in UniProtKB (15)
| IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells. Imataki O., Ansen S., Tanaka M., Butler M.O., Berezovskaya A., Milstein M.I., Kuzushima K., Nadler L.M., Hirano N. J. Immunol. 188:1609-1619(2012) · Mapped (8) |
| Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell. Tanaka M., Butler M.O., Ansen S., Imataki O., Berezovskaya A., Nadler L.M., Hirano N. Clin. Cancer Res. 17:5392-5401(2011) · Mapped (9) |
| Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival. Maia S., Pelletier M., Ding J., Hsu Y.M., Sallan S.E., Rao S.P., Nadler L.M., Cardoso A.A. PLoS ONE 6:e20787-e20787(2011) · UniProtKB (2) · Mapped (11) |
| Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors. Batista A., Barata J.T., Raderschall E., Sallan S.E., Carlesso N., Nadler L.M., Cardoso A.A. Exp. Hematol. 39:457-472.e3(2011) · Mapped (5) |
| Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21. Ansen S., Butler M.O., Berezovskaya A., Murray A.P., Stevenson K., Nadler L.M., Hirano N. Clin. Cancer Res. 14:6125-6136(2008) · Mapped (1) |
| Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling. Cardoso B.A., Martins L.R., Santos C.I., Nadler L.M., Boussiotis V.A., Cardoso A.A., Barata J.T. Leukemia 23:206-208(2009) · Mapped (13) |
| CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants. von Bergwelt-Baildon M., Shimabukuro-Vornhagen A., Popov A., Klein-Gonzalez N., Fiore F., Debey S., Draube A., Maecker B., Menezes I., Nadler L.M. et al. Blood 107:2786-2789(2006) · Mapped (3) |
| Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB. Costa L.F., Balcells M., Edelman E.R., Nadler L.M., Cardoso A.A. Blood 107:285-292(2006) · Mapped (5) |
| Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. Barata J.T., Silva A., Brandao J.G., Nadler L.M., Cardoso A.A., Boussiotis V.A. J. Exp. Med. 200:659-669(2004) · Mapped (8) |
| Differential localization and function of ADP-ribosylation factor-6 in anergic human T cells: a potential marker for their identification. Tzachanis D., Appleman L.J., Van Puijenbroek A.A., Berezovskaya A., Nadler L.M., Boussiotis V.A. J. Immunol. 171:1691-1696(2003) · Mapped (3) |
| cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression. Grader-Beck T., van Puijenbroek A.A., Nadler L.M., Boussiotis V.A. Blood 101:998-1006(2003) · Mapped (3) |
| CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. Appleman L.J., van Puijenbroek A.A., Shu K.M., Nadler L.M., Boussiotis V.A. J. Immunol. 168:2729-2736(2002) · Mapped (11) |
| Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Tzachanis D., Berezovskaya A., Nadler L.M., Boussiotis V.A. Blood 99:1465-1473(2002) · Mapped (8) |
| Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms. Datta M.W., Shahsafaei A., Nadler L.M., Freeman G.J., Dorfman D.M. Appl. Immunohistochem. Mol. Morphol. 8:210-215(2000) |
| Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. Anumanthan A., Bensussan A., Boumsell L., Christ A.D., Blumberg R.S., Voss S.D., Patel A.T., Robertson M.J., Nadler L.M., Freeman G.J. J. Immunol. 161:2780-2790(1998) · UniProtKB (2) |
| Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Hall K.T., Boumsell L., Schultze J.L., Boussiotis V.A., Dorfman D.M., Cardoso A.A., Bensussan A., Nadler L.M., Freeman G.J. Proc. Natl. Acad. Sci. U.S.A. 93:11780-11785(1996) · UniProtKB (1) |
| Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Freeman G.J., Gribben J.G., Boussiotis V.A., Ng J.W., Restivo V.A. Jr., Lombard L.A., Gray G.S., Nadler L.M. Science 262:909-911(1993) · UniProtKB (1) |
| Characterization of the murine B7-1 genomic locus reveals an additional exon encoding an alternative cytoplasmic domain and a chromosomal location of chromosome 16, band B5. Borriello F., Freeman G.J., Edelhoff S., Disteche C.M., Nadler L.M., Sharpe A.H. J. Immunol. 153:5038-5048(1994) · UniProtKB (3) · Mapped (4) |
| The B7 and CD28 receptor families. June C.H., Bluestone J.A., Nadler L.M., Thompson C.B. Immunol. Today 15:321-331(1994) · Mapped (4) |
| The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen. Engel P., Gribben J.G., Freeman G.J., Zhou L.J., Nozawa Y., Abe M., Nadler L.M., Wakasa H., Tedder T.F. Blood 84:1402-1407(1994) · UniProtKB (1) |
| Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. Lenschow D.J., Sperling A.I., Cooke M.P., Freeman G., Rhee L., Decker D.C., Gray G., Nadler L.M., Goodnow C.C., Bluestone J.A. J. Immunol. 153:1990-1997(1994) · Mapped (10) |
| Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. Freeman G.J., Borriello F., Hodes R.J., Reiser H., Gribben J.G., Ng J.W., Kim J., Goldberg J.M., Hathcock K., Laszlo G. et al. J. Exp. Med. 178:2185-2192(1993) · UniProtKB (1) · Mapped (15) |
| Differential expression of alternate mB7-2 transcripts. Borriello F., Oliveros J., Freeman G.J., Nadler L.M., Sharpe A.H. J. Immunol. 155:5490-5497(1995) · UniProtKB (3) · Mapped (5) |
| B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. Nadler L.M., Anderson K.C., Marti G., Bates M., Park E., Daley J.F., Schlossman S.F. J. Immunol. 131:244-250(1983) · Mapped (4) |
| B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. Freeman G.J., Freedman A.S., Segil J.M., Lee G., Whitman J.F., Nadler L.M. J. Immunol. 143:2714-2722(1989) · UniProtKB (1) |